Schneider MR - Search Results

1

Growth-stimulating effect of adrenal androgens on the R3327 Dunning prostatic carcinoma.

Schiller CD, Schneider MR, Hartmann H, Graf AH, Klocker H, Bartsch G. Schiller CD, et al. Among authors: schneider mr. Urol Res. 1991;19(1):7-13. doi: 10.1007/BF00294013. Urol Res. 1991. PMID: 1827559

2

Effect of zindoxifene on experimental prostatic tumours of the rat.

Schneider MR, Schiller CD, Humm A, von Angerer E. Schneider MR, et al. J Cancer Res Clin Oncol. 1991;117(1):33-6. doi: 10.1007/BF01613193. J Cancer Res Clin Oncol. 1991. PMID: 1997466

3

The tumor-inhibiting effect of diethylstilbestrol and its diphosphate on the Nb-H and Nb-R prostatic carcinomas of the rat.

Schneider MR, Humm A, Graf AH. Schneider MR, et al. J Cancer Res Clin Oncol. 1990;116(2):159-67. doi: 10.1007/BF01612671. J Cancer Res Clin Oncol. 1990. PMID: 2324159

4

[Hydroxy substituted phenyltetralines: compounds with affinity for estrogen and androgen receptors].

Schneider MR, Schiller CD. Schneider MR, et al. Arch Pharm (Weinheim). 1990 Jan;323(1):17-21. doi: 10.1002/ardp.19903230106. Arch Pharm (Weinheim). 1990. PMID: 2334266 German.

5

[1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloro-platinum(II): an endocrine-active platinum complex with a specific prostatic tumor-inhibiting activity.

Schneider MR, Schiller CD, Humm A, Spruss T, Schönenberger H, Amselgruber W, Sinowatz F. Schneider MR, et al. Prostate. 1989;15(2):135-48. doi: 10.1002/pros.2990150207. Prostate. 1989. PMID: 2798231

6

6,7-Dihydro-4H-indolones: synthesis and biological properties.

Schiller CD, von Angerer E, Schneider MR. Schiller CD, et al. Among authors: schneider mr. Arch Pharm (Weinheim). 1991 Oct;324(10):767-71. doi: 10.1002/ardp.2503241001. Arch Pharm (Weinheim). 1991. PMID: 1805709

7

3-(Cyclohexenonyl)-4-(4-hydroxyphenyl)-hexanes: antiandrogenes derived from the estrogen hexestrol.

Schiller CD, Schneider MR, von Angerer E. Schiller CD, et al. Among authors: schneider mr. Arch Pharm (Weinheim). 1990 Jul;323(7):417-20. doi: 10.1002/ardp.19903230708. Arch Pharm (Weinheim). 1990. PMID: 2173517

8

Carrier mediated action of platinum complexes on estrogen receptor positive tumors.

Knebel N, Schiller CD, Schneider MR, Schönenberger H, von Angerer E. Knebel N, et al. Among authors: schneider mr. Eur J Cancer Clin Oncol. 1989 Feb;25(2):293-9. doi: 10.1016/0277-5379(89)90022-9. Eur J Cancer Clin Oncol. 1989. PMID: 2702983

9

Platinum(II) complexes interfering with testicular steroid biosynthesis: drugs for the therapy of advanced or recurrent prostate cancers? Preclinical studies.

Schertl S, Hartmann RW, Batzl-Hartmann C, Spruss T, Maucher A, von Angerer E, Schiller CD, Schneider MR, Gust R, Schönenberger H. Schertl S, et al. Among authors: schneider mr. J Cancer Res Clin Oncol. 2007 Mar;133(3):153-67. doi: 10.1007/s00432-006-0151-3. Epub 2006 Oct 6. J Cancer Res Clin Oncol. 2007. PMID: 17024493

10

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.

Culig Z, Hoffmann J, Erdel M, Eder IE, Hobisch A, Hittmair A, Bartsch G, Utermann G, Schneider MR, Parczyk K, Klocker H. Culig Z, et al. Among authors: schneider mr. Br J Cancer. 1999 Sep;81(2):242-51. doi: 10.1038/sj.bjc.6690684. Br J Cancer. 1999. PMID: 10496349 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters